Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Identify the most severe drawdowns in index fund history and review their recovery paths to inform risk management.
16,017 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
A new survey of 351 institutions finds 25% intend to add XRP in 2026, joining the 18% already holding the token. Pric...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
A timely tribute to Ted Turner and the daring moves that built a media empire. From billboard prince to cable mogul, ...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
Poppi’s journey shows how founders turn personal risk into billion-dollar exits. The cofounder maxed credit and even ...
A new White House mascot, meet ‘coalie,’ anime-style anthropomorphic coal, is shaping how investors view energy polic...
A new Allianz study shows 59% of households in the sandwich generation reduced retirement contributions to support lo...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
BTBT's Q4 2025 earnings shed light on mining efficiency, energy spend, and bitcoin price risks. This guide breaks dow...
A new AI-based forecast points to a sharp XRP rally by end-2026, with potential moves beyond current ranges as regula...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...